drugset / Trial / NCT00156208
Safety of Treatment of Uterine Fibroids With Asoprisnil
Non-randomizedParallel-groupSingle-blindTreatment
Summary
The objective of this study is to determine the long-term safety of asoprisnil in women with symptomatic uterine fibroids who completed the 6 month Study C02-037.
Timeline
- Start
- 2004-04
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asoprisnil | Other / unclassified | 10 mg | Oral |
| Subject | Asoprisnil | Other / unclassified | 25 mg | Oral |